ProQR Therapeutics NV (PRQR)
1.985
-0.02
(-0.75%)
USD |
NASDAQ |
May 02, 14:39
ProQR Therapeutics Total Assets (Quarterly): 152.42M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 152.42M |
| September 30, 2023 | 150.34M |
| June 30, 2023 | 160.83M |
| March 31, 2023 | 172.30M |
| December 31, 2022 | 183.72M |
| September 30, 2022 | 119.65M |
| June 30, 2022 | 187.04M |
| March 31, 2022 | 212.32M |
| December 31, 2021 | 237.29M |
| September 30, 2021 | 226.56M |
| June 30, 2021 | 193.21M |
| March 31, 2021 | 107.39M |
| December 31, 2020 | 121.43M |
| September 30, 2020 | 129.37M |
| June 30, 2020 | 105.16M |
| March 31, 2020 | 114.30M |
| December 31, 2019 | 131.66M |
| September 30, 2019 | 88.69M |
| June 30, 2019 | 102.62M |
| March 31, 2019 | 114.12M |
| Date | Value |
|---|---|
| December 31, 2018 | 126.09M |
| September 30, 2018 | 138.27M |
| June 30, 2018 | 43.41M |
| March 31, 2018 | 52.11M |
| December 31, 2017 | 63.71M |
| September 30, 2017 | 53.71M |
| June 30, 2017 | 55.35M |
| March 31, 2017 | 62.12M |
| December 31, 2016 | 69.29M |
| September 30, 2016 | 81.70M |
| June 30, 2016 | 93.36M |
| March 31, 2016 | 103.58M |
| December 31, 2015 | 109.45M |
| September 30, 2015 | 117.90M |
| June 30, 2015 | 124.53M |
| March 31, 2015 | 127.34M |
| December 31, 2014 | 140.14M |
| September 30, 2014 | 147.99M |
| June 30, 2014 | 53.35M |
| December 31, 2013 | 6.219M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
88.69M
Minimum
Sep 2019
237.29M
Maximum
Dec 2021
152.44M
Average
150.34M
Median
Sep 2023
Total Assets (Quarterly) Benchmarks
| uniQure NV | 831.69M |
| Merus NV | 455.49M |
| argenx SE | 4.542B |
| Pharming Group | 462.85M |
| Pharvaris NV | 440.72M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 106.66M |
| Shareholders Equity (Quarterly) | 45.75M |
| Debt to Equity Ratio | 0.1037 |
| Current Ratio | 3.537 |
| Net Debt Paydown Yield | 0.22% |